Viewing Study NCT00527657

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2026-02-21 @ 1:34 AM
Study NCT ID: NCT00527657
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2007-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Neoplasms View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Brain Neoplasms View
None Melanoma View
None Metastatic Melanoma View
None Brain Metastasis View
None Temozolomide View
None Temodar View
None Thalidomide View
None Thalomid View
None Lomustine View
None CCNU View
None CeeNU View